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Cloning and Analysis of Putative Collagenases of the U32 Family in
Streptococcus mutans and Streptococcus agalactiae (Group B Streptococci)
Valerie Carson
ABSTRACT
Analysis of the genomic sequences of Streptococcus mutans UA159 and
Group B Streptococcus (GBS) strains Streptococcus agalactiae NEM316 and S.
agalactiae 2603V/R indicated the presence of two putative collagenase genes in
each organism. smcol1 from S. mutans was previously cloned and analyzed and
the results indicated that the enzyme belonged to the U32 family of
collagenases/peptidases.

This enzyme shares homology with the prtC of

Porphyromonas gingivalis, one of the principal examples of the U32 family of
peptidases. Considering the potential role of these enzymes in the pathogenicity
of P. gingivalis (periodontitis or gum disease), GBS (premature rupture of the
amniochorionic membrane) and S. mutans (dental root decay), it is necessary to
study these enzymes and establish their role in the virulence of these organisms.
Toward this goal the present study has focused on cloning collagenase 2
(smcol2) from S. mutans and cloning collagenase 1 (gbscol1), and collagenase 2
(gbscol2), from GBS.

The information obtained will contribute to a further

understanding of the U32 peptidase family.

v

INTRODUCTION
Collagen is a major structural protein in our bodies, making up a large
percentage of human tissue, from the skin to the tendons, eyes, bones, amniotic
membrane and teeth. In the mouth, collagen is one of the main components of
gingival connective tissue and it is found in the matrix of alveolar bone and
cementum, dentin of the tooth and in the basement membrane beneath the
gingival epithelium (37).

Periodontal tissue is made up primarily of type I

collagen, which is made up of three parallel polypeptide chains composed of the
sequence

Gly-X-Y,

with

X

representing

proline

and

Y

representing

hydroxyproline. These amino acids give collagen stability and restrict the rotation
of the polypeptide backbone (10). Collagen is extremely resistant to degradation
because of its tightly coiled triple helix structure that is stabilized by hydrogen
bonds and cross-linking and can only be cleaved by collagenases (20).
Until recently it was thought that only a few species of bacteria produced
collagenases, namely Clostridium and Vibrio alginolyticus, but numerous other
human pathogens have also been reported to have the ability to break down
collagen (17). The specificity of bacterial collagenases is very broad and, unlike
vertebrate collagenases that are more specific in their cleavage sites (33),
bacterial collagenases are capable of hydrolyzing denatured as well as native
collagen. Gelatin is produced when collagen loses its triple helix structure and
1

becomes denatured.

Numerous mammalian proteases are able to hydrolyze

gelatin, including pepsin, trypsin and papain. Hydrolysis of collagen may help in
bacterial infection and spreading, hence collagenase has been considered as a
virulence factor and the focus of numerous studies.
The most widely studied collagenase is a metalloprotease produced by
Clostridium histolyticum (32) that requires a zinc molecule to retain its hydrolytic
activity (47).

This zinc-metalloprotease is unique in that it is able to cleave

denatured and native collagen (32). Subsequently, C. histolyticum has been
found to produce different types of collagenases, which are separated into two
classes based on their amino acid sequences and peptide substrate
requirements (31). C. histolyticum colH is a 116 kDa collagenase that co-purifies
with a 98 kDa protein, which cleaves denatured collagen, but not native collagen
(47). Because they share identical N-terminal sequences and peptide maps, it is
believed that the 98 kDa gelatinase is produced by the cleavage of the Cterminal end of the 116 kDa collagenase (32). C. histolyticum also produces
another collagenase, ColG. It was found that colG and colH are less than 760 kb
apart on C. histolyticum’s genome. It is hypothesized that the presence of these
similar clostridial collagenase genes is due to gene duplication and later
divergence (31).
Periodontitis is a collection of diseases involving the destruction of structural
proteins in the oral cavity (37) . Periodontal diseases, which are characterized by
the destruction of collagen, vary in severity depending on the stage of
development, age of the patient and reaction to treatment. Degradation of
2

gingival connective tissue, the supporting structure of the tooth, including type I
collagen, leads to periodontal lesions. Numerous studies have shown that in
regions of periodontal tissue degradation, extensive collagenase activity is
evident (38).

Collagenase activity by bacteria of the oral cavity were first

discovered in the 1960’s (17). Hence, an understanding of how bacteria interact
with collagen of the periodontium is a necessary tool in the understanding of their
pathogenecity.
A common bacterium isolated from infected individuals suffering from
advanced periodontitis is Porphyromonas gingivalis (27). This organism has
collagenases, one of which is encoded by prtC. The prtC enzyme was found to
be able to break down soluble type I collagen (38), as well as fibrillar collagen;
however it could not degrade the synthetic collagenase substrate, PZ-PLGPA,
gelatin nor denatured type I collagen (27). The ability of P. gingivalis to cleave
native type I collagen was eliminated by the inactivation of one of the two genes
encoding Arg-gingipain A or B (20), suggesting that the collagenase activity of P.
gingivalis requires the action of both enzymes (27). It was also found that the
activity of these two enzymes is dependent on their association with the bacterial
cell wall, given that purified enzymes showed no activity (20). Indeed, prtC was
classified in the U32 family of peptidases/collagenases based on the presence of
a consensus sequence.
One of the most widespread and expensive infectious diseases in the world is
dental caries (11), of which S. mutans is the primary etiological agent. It has
been found that if oral streptococci are inhibited on the root surface, the
3

development of dental caries is greatly diminished (40). Dental caries results
from the acidic end products produced by the metabolism of fermentable
carbohydrates in the diet. This drastically decreases the pH in the oral cavity
which leads to the dissolution of the tooth enamel and root surface (45).

Dental

caries is a public health problem world-wide, hence extensive research effort has
focused on developing means to prevent this infectious disease. Kassab et al,
determined that approximately 24 million people in the United States have tooth
surfaces that have 3 millimeters or greater of gingival recession and that the
occurrence of gingival recession increased with age and was higher in men
compared to women of the same age (26). Fluoridation of water and dental
hygiene showed limited success. With current medical research, the average life
span has greatly increased, but along with this, the occurrence of dental root
decay has also increased.
Dentin, unlike the tooth crown, is made up of organic components and
hydroxyapatite, an inorganic material (10). The organic component of dentin is
composed of about 90% type I collagen, citrate, lipids and non-collagenous
proteins. Root caries begin by exposure of the root surface to the oral
environment via recession of the gum and subsequently the exposed dentin
becomes vulnerable to microbial infection, which can lead to loss of the tooth
(10). Gingival recession, which is defined as the dislocation of the gingival tissue
and exposure of the root, can be localized or generalized (26). It has recently
been shown that greater than 50% of the general population had one or more
locations with gingival recession of 1 millimeter or greater. Many factors are
4

associated with gingival recession, including age, lack of alveolar bone, the
abnormal tooth position, and vigorous tooth brushing (26). The main factors
involved in the progression of root caries is the invasion of bacteria into the
dentin and fermentable carbohydrates derived from the host’s diet (5).
Development of root and coronal caries differs greatly. Root caries involve
the decomposition of dentin minerals while coronal caries involves enamel
demineralization.

Root surface caries seem to be more complex in their

treatment and pathology as compared to coronal caries although both types of
caries involve acidic demineralization (10). The rate at which coronal and root
caries proceeds also differs. The destruction of dentin transpires about twice as
quickly as the demineralization of the enamel, due to the fact that the crown is
composed of almost double the amount of minerals (5).
One study showed that the microflora that colonized isolated dentin
specimens from patients were composed of a diverse community of bacteria
(41). Numerous microorganisms have been isolated from root caries lesions
including, Actinomyces spp, Streptococcus spp, and Lactobacillus spp (3). It has
been found that Actinomyces and Streptococcus where the dominant species
isolated from root surface lesions (41). S. mutans is routinely found in root caries
plaque samples and has been shown to be one of the major players in root
caries disease (3). It has also been found that the inhibition of streptococci at the
root surface leads to the decline of root caries (42).

S. mutans produces a

number of proteins that are associated with its cell wall and have been implicated
as virulence factors, hence they are the focus of research regarding S. mutans
5

and dental caries (15, 40). Antibodies against these antigens could possibly
thwart the development of dental caries by S. mutans. The main objective for an
anti-dental caries vaccine would be to prevent S. mutans from attaching and
adhering to oral tissues, which could lead to the prevention of tooth decay on the
surface and root of the tooth. With the increasing technology in recombinant
DNA techniques, research has focused on identifying and isolating genes
involved in the pathogenicity of S. mutans. Numerous genes that are involved in
coronal caries, such as polymer-forming glucosyltransferases, fructosyltransferases, and wall associated protein A have been cloned and sequenced
(12, 45). In studies where cell wall fractions were exposed to proteases, animals
that were immunized with the suspension were not protected against dental
caries (13). Indeed, the identification of these cell-surface proteins as potential
immunogens against dental caries should be further investigated.
Degradation of collagen in tissues of the dento-epithelial seam leads to the
development of a region that has a redox potential level that is lower than that of
the surrounding tissue (17).

This environment promotes the colonization of

anaerobic organisms which can lead to periodontal disease. Infection with S.
mutans has been shown to degrade the periodontal ligament, instigate the
massive loss of bone, while the production of collagenase activity in this
organism was substantiated by its ability to hydrolyze collagen fibrils in rat tail
tendons (17, 18). S. mutans has been found in human root surface carious
lesions and is able to bind collagen type I and II (22). S. mutans has been shown
to possess two extracellular proteases that can hydrolyze PZ-PLGPA and
6

breakdown type I collagen (18). It is speculated that these enzymes may be a
factor in the degradation of collagen of the dentin and cementum of the oral
cavity (17). Switalski et al. (42) found that S. mutans was able to bind collagen
in dentin and that it may have a profound effect on the development of root
surface caries.

It was also demonstrated that S. mutans strain GS-5 was

capable of breaking down alveolar bone and collagen of the periodontal ligament
(18). Jackson et al. demonstrated cell-associated collagenase activities in S.
mutans (22). It was found that S. mutans was able to bind collagen and that cell
lysate from S. mutans cross-reacted with antiserum to collagenase from C.
histolyticum (22). These characteristics taken together lend to the fact that S.
mutans plays a considerable role in the pathogenesis of dentinal caries. These
virulent factors may aid S. mutans in maintaining its environmental niche in the
oral cavity and contribute to its ability to cause host tissue damage.
A great deal of focus has been directed on producing a vaccine against
coronal caries (16, 24), but this will have no effect on the colonization of dental
root by S. mutans and subsequent destruction of the root dentine. While coronal
caries involves surface adhesins with binding affinity for salivary pellicles and
glucan-binding proteins (42), dental root decay is mediated by collagen-binding
protein and collagen degrading enzymes. More research is needed in order to
identify and characterize the factors involved in dental root caries in order to
develop specific prophylactic measures.
Streptococcus agalactiae, also referred to as Group B streptococci (GBS), is
the leading cause of severe neonatal bacterial infections, including pneumonia,
7

sepsis and meningitis. In the United States, about 10,000 instances of GBS
infections occur with a 15% mortality ratio (28, 36), being responsible for two to
three cases per 1000 live births (14). GBS can be found living asymptomatically
in the vaginal epithelium and the lower gastrointestinal tract of healthy adults.
GBS has a competitive advantage over other microflora in the vaginal epithelium
since it is able to attach to the epithelium and survive in the low pH environment.
It is estimated that 10-40% of women who are pregnant are infected with GBS
and that 40-70% of these women transmit the bacterium to their child (7).
Human newborns contract GBS when they pass through the birth canal or
swallow infected amniotic fluid from their mother (30). GBS does not only infect
neonates and pregnant women, it also affects people with chronic conditions and
the elderly. The incidence of invasive GBS infections has steadily increased in
recent years for the immunocompromised and the elderly to numbers similar to
the incidence of the newborn population (30).

Most newborn that become

infected with GBS do not develop disease, but the range of virulence factors
attributed to GBS can lead to infection when the infant’s immune system fails.
These virulence factors include its ability to hinder the newborns defensive
system, factors that allow the organism to infect the bloodstream and deep tissue
by its ability to invade the epithelial and endothelial barriers, the production of
toxins, and mechanisms that allow inflammatory reactions in the host (30). When
an infant is born prematurely, the likelihood that the infected newborn will
become symptomatic is greatly increased. Generally, 1-3% of infected babies
develop early-onset disease (sepsis and meningitis) within the first 24 hours after
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birth (7). It has been suggested that vaginal infection or inflammation is linked to
preterm rupture of the amniotic membrane and preterm labor (44). Labor before
37 weeks gestation is considered preterm labor (PTL) and delivery (PTD) and is
usually preceded by pre-mature rupture of membranes (PPROM) (39). PTL and
PTD is generally caused by such factors as: smoking, alcoholism, poor nutrition,
health disorders, PROM, multiple gestation, placental abruption and bacterial
infection (39).

The main cause of PPROM and PTL can be contributed to

bacterial infections (39). About 12% of pregnancies in 2001 were caused by
preterm birth, with the number of preterm babies being born progressively
increasing (39). In premature labors, it has been found that there is a decreased
concentration of collagen (44). The fetal membrane is composed of collagen
types I, III, and V (2), with type I and type V giving the amniotic membrane its
strength (35).
It is hypothesized that GBS may be involved in the premature rupture of the
amniotic tissue based on the fact that infection with this organism was associated
with the degradation of the amniochorionic membrane and on its ability to
degrade the synthetic peptide FALGPA, which mimics collagen (23). However, it
was found that GBS was incapable of degrading a film of reconstituted rat tail
collagen (30). Lin et al. (29) further isolated and tested the suspected
collagenase and speculated that it was not a collagenase but an oligopeptidase,
belonging to the M3 oligopeptidase family of metallopeptidases. Since the paper
has been published, two strains of S. agalactiae, 2603V/R (43) and NEM316
(14), have been sequenced and submitted online at www.ncbi.nlm.nih.gov.
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Based on sequence analysis of both strains, it was found that S. agalactiae does
indeed have a gene (gbs0824 from strain NEM316 and SAG0805 from strain
2603V/R) similar to pepF from Lactococcus lactis (66.4% identity, data not
shown), which is also an M3 oligopeptidase and displayed many of the same
properties as members of this family.
Peptidases are categorized into clans and families where clans represent sets
of families that share common ancestry and families are arranged by their
catalytic specifications. The peptidase clan U- belongs to MEROPS peptidase
family U32 of the clan U- and has an unknown catalytic mechanism. It also
contains the consensus pattern: E-x-F-x(2)-G-[SA]-[LIVM]-C-x(4)-G-x-C-x-[LIVM]S.

The most studied peptidase of this family is the prtC collagenase from

Porphyromonas gingivalis, which is capable of degrading type I collagen and
may require a metal cofactor. It is able to degrade soluble type I collagen but not
gelatin or synthetic collagenase substrates.
The availability of sequenced genomes online has allowed a more thorough
search and analysis of bacterial genomes.

And with the convenience of

molecular genomics, such as PCR and cloning into expression vectors, it is now
possible to easily and efficiently study virulence factors from pathogens.
Recently, our lab has isolated and characterized a collagenase gene (smcol1) of
the U32 peptidase family from S. mutans (Ioannides, Biology MS thesis, USF,
2004). smcol1 was cloned and expressed in Escherichia coli and the
recombinant protein was purified and studied. The smcol1 was shown to be
identical to the SMU.761 protease in S. mutans UA159.
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Preliminary analysis of the S. mutans UA159 indicated the presence of
another putative collagenase (col2) encoded by a gene upstream from smcol1
(SMU.759). Similar enzymes to S. mutans col1 and col2 were also identified in
the analysis of GBS NEM316 and 2603V/R genomic sequences (gbs0762 and
gbs0763 in GBS NEM316, and SAG0741 and SAG0742 in strain 2603V/R). The
goal of the present study was to clone smcol2, gbscol1 and gbscol2 into E. coli
TOP10 using the arabinose-inducible expression vector system pBAD TOPO®
TA (Invitrogen), which allows the expression and purification of soluble
recombinant His-tagged protein. Recombinant proteins will be analyzed for
collagenase and gelatinase activity. The results obtained in the present studies
will add to our understanding of S. mutans and GBS role in their respective
pathogenicity.

11

MATERIALS AND METHODS

Chemicals and Reagents
Primers for PCR were produced by Operon Biotechnologies (Huntsville,
AL).

PCR reagents, restriction enzymes, The Wizard® Genomic DNA

Purification Kit and The Wizard® Plus Minipreps Plasmid DNA Purification
System were obtained from Promega Inc. (Madison, WI) and used in accordance
to the manufacturer’s protocols. The expression vector, pBAD TOPO® TA was
obtained from Invitrogen Life Technologies (Carlsbad, CA). All other reagents
and chemicals were purchased from Sigma-Aldrich Co. (St. Louis, MO), Fisher
Scientific (Pittsburg, PA), or Bio-Rad Laboratories (Hercules, CA) unless
otherwise specified.

Bacterial Strains and Growth Conditions
S. mutans GS-5 serotype c, was initially obtained from J. J. Ferretti
(University of Oklahoma Health Sciences Center, Oklahoma City, OK). GBS
USF704 (serotype Ib/c, α, β, γ) is a β-hemolytic clinical isolate originally obtained
from a septic newborn and was acquired from Dr. Daniel Lim (University of South
Florida Department of Biology and Center for Biological Defense, Tampa, FL).
Both strains were cultured at 37ºC in BHI broth with 5% CO2.

Chemically

competent E. coli TOP10 cells were obtained from Invitrogen and used in the
12

cloning and expression of all recombinant plasmids. Luria-Bertani (LB) medium
(Difco, Detroit, MI) containing 100 µg/ml ampicillin (LBA) was used in the
selection of transformants and the culturing of recombinant clones expressing the
collagenase genes.

Bioinformatical Analysis
The sequences used for the cloning and analysis of the collagenase 2 gene
(smcol2) from S. mutans and the collagenase 1 (gbscol1), and collagenase 2
(gbscol2) genes from GBS were obtained from the National Center for
Biotechnology Information (NCBI) Entrez server. The sequenced genomes of S.
mutans UA159 (Accession # AE0141) and S. agalactiae NEM316 serotype III
strain (Accession # AL732656) and S. agalactiae 2603V/R serotype V
(Accession # AE009948) were used for the genomic analysis of the
collagenases.

Alignment analysis was performed using the ClustalW WWW

Service at the European Bioinformatics Institute (19). Signal peptide analysis
was derived from PSIPRED Protein Structure Prediction Server (25, 34).

Isolation of Genomic DNA
The isolation of genomic DNA was accomplished using a genomic DNA
purification kit (Promega’s Wizard®). The isolation was performed according to
the manufacturer’s protocol.

Briefly, 1 ml from an overnight culture was

centrifuged at 16,000 x g for 2 minutes and the supernatant removed. The cell
pellet was resuspended in 480 µl of 50 mM EDTA.
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120 µl of 10 mg/ml of

lysozyme was added to the cell suspension and incubated at 37°C for 1 hour to
weaken the cell wall. The samples were centrifuged at 16,000 x g for 2 minutes.
The supernatant was removed and 600 µl of Nuclei Lysis Solution was added to
the samples and incubated at 80°C for 5 minutes to lyse the cells. The solution
was cooled to room temperature. 3 µl of RNase Solution was added to the cell
lysate and incubated at 37°C for 45 minutes. 200 µl of Protein Precipitation
Solution was added to the RNase-treated cell lysate and incubated for 5 minutes
on ice. The samples were then centrifuged at 16,000 x g for 3 minutes. The
supernatant containing the DNA was transferred to a clean 1.5 microcentrifuge
tube and 600 µl of room temperature isopropanol was gently mixed with the
DNA. The mixture was centrifuged at 16,000 x g for 2 minutes. The supernatant
was gently aspirated off and 70% ethanol was added to the pellet.

The

suspension was again centrifuged at 16,000 x g for 2 minutes and the ethanol
aspirated. The pellet was allowed to air dry for 3 hours and 100 µl of DNA
Rehydration Solution was added to rehydrate the DNA pellet. The purity and
concentration of the DNA was determined by analysis on a 1% agarose gel and
measurement

on

the

SmartSpec

Plus

Spectrophotometer

(Bio-Rad

Hercules, CA).

PCR Amplification of S. mutans and S. agalactiae Genomic DNA
Using purified genomic DNA from S. mutans GS-5 as a template, PCR was
performed to amplify the collagenase 2 gene (smcol2). Primers were designed
based on the sequenced genome of S. mutans UA159 (9). Four primer sets
14

were developed to amplify the gene with and without the signal peptide.

The

gene was also amplified with and without the native stop in order to include the
V5 epitope and the polyhistidine region of the pBAD vector. PCR was performed
using four different primer sets (Table 1) to amplify the smcol2 gene from S.
mutans GS-5 genomic DNA under the following conditions: an initial denaturation
step at 95ºC for 2 minutes. Then 30 cycles of the following: 95ºC for 1 minute
(denaturation step), 1 minute at the corresponding annealing temperature for the
specific primer (annealing step), and 72ºC for 1 minute (extension step). Lastly,
a final extension step was done at 72ºC for 10 minutes. The PCR mixture used
contained the following: 12.5 µl of PCR Master Mix (Promega), 0.2 µM of the
forward primer, 0.2 µM of the reverse primer, 25 ng of genomic DNA, and 10.5 µl
of H2O. The PCR products were analyzed by electrophoresis on a 1% agarose
gel. The DNA was stained with ethidium bromide and viewed under ultraviolet
light.
smcol2
Clones
Clone 1

Forward
Primer
Includes the
signal peptide

Clone 2

Includes the
signal peptide

Clone 3

Excludes the
signal peptide

Clone 4

Excludes the
signal peptide

Reverse Primer
5’ATGGAAAAAA
TTGTTATCACT
GCGACTGC
5’ATGGAAAAAA
TTGTTATCACT
GCGACTGC
5’AATATTAAAC
CATTTTTAGAA
TTAATGAAGGA
AATTCAG
5’AATATTAAAC
CATTTTTAGAA
TTAATGAAGGA
AATTCAG

Contains native
stop
Does not contain
native stop
Contains native
stop
Does not contain
native stop

5’TTACTTAAC
TGTTTGCGG
ATCAAGC
5’CTTAACTGT
TTGCGGATC
AAGC
5’TTACTTAAC
TGTTTGCGG
ATCAAGC
5’CTTAACTGT
TTGCGGATC
AAGC

Table 1. PCR primers used in the amplification of smcol2
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Annealing
Temp
55.0ºC
56.8ºC
55.4ºC

55.4ºC

The sequences for genes SAG0741, SAG0742, gbs0762 and gbs0763 of
S.agalactiae 2603V/R (43) and S. agalactiae NEM316 (14), respectively, were
used to develop primers for the gbscol1 and gbscol2 genes. The reason for this
selection is based on the highest homology each one has with the corresponding
enzyme in S. mutans.
SAG0742 and gbs0763 were used to design primers for gbscol1
Forward = 5’ ATGTCTAATGTAAAAAAACGCCCT
Reverse = 5’ AGCTCTTACAGTCTTGCTAG
SAG0741 and gbs0762 were used to design primers for gbscol2
Forward = 5’ ATGGAAAAAATAATTTTGACAGCGAC
Reverse = 5’ TTTTACTGTTGATGGGTCAAAATC
PCR conditions were optimized for the specific primers and the conditions
were as described above.

The specific annealing temperature for the gbscol1

primers was 52.7ºC and 51.6ºC for gbscol2 primers (Operon Biotechnologies).

Cloning of the smcol2, gbscol1 and gbscol2 Genes into the pBAD-TOPO®
TA Vector
Once the correct size of the PCR products was verified on a 1% agarose gel,
the products were cloned into the pBAD TOPO® TA vector (Figure 1). Briefly, for
the cloning reaction, 2 µl of fresh PCR product was mixed with 1 µl of pBAD
vector, 1 µl of salt solution (1.2 M NaCl and 0.06 M MgCl2) and 1 µl of H2O and
allowed to incubate at 24ºC for 5 minutes. The cloning mixture was then placed
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on ice and 2 µl was mixed with 250 µl of One Shot® TOP10 Chemically
Competent E. coli cells (Invitrogen). The cells were incubated on ice for 15
minutes. Transformation was by heat shock treatment: 30 seconds in a 42ºC
water bath followed by immediate cooling on ice.

250 µl of S.O.C. medium

(Invitrogen) was added to the cells and they were horizontally incubated at 37ºC
for one hour with shaking. Finally, 20 µl and 40 µl samples were cultured on prewarmed LBA plates. The plates were incubated for 24 hours at 37ºC. After
incubation, five ampicillin resistant (AmpR) clones from each cloning reactions
were chosen at random for further screening of each gene.

Figure 1. Map of the expression vector pBAD TOPO® TA (Invitrogen)
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Analysis of the Recombinant Plasmids
Plasmid DNA was isolated from the clones using the FastPlasmid™ Mini kit
from Eppendorf (Westbury, NY) following the manufacturer’s protocol. Briefly,
the AmpR transformants containing the recombinant plasmids were grown in LBA
for 16 hours at 37ºC with shaking. 1.5 µl of each culture was centrifuged at
16,000 x g for 1 minute and the supernatant was removed. 400 µl of the Lysis
Solution was added to the pellet and resuspended with vigorous mixing. The
mixture was then incubated for 3 minute at 24°C. The lysate was removed and
transferred to a spin column assembly that was then centrifuged for 1 minute at
16,000 x g. The spin column assembly was washed with 400 µl of diluted wash
buffer and centrifuged for 1 minute. The solution in the bottom of the tube was
decanted and the spin column assembly was centrifuged for an additional minute
to remove any excess isopropanol from the assembly. The spin column was then
transferred to a clean tube and the plasmid DNA was eluted off by adding 30 µl
of elution buffer and centrifuging at 16,000 x g for 1 minute.
The presence of the inserts was verified by PCR using the reverse and
forward primers specific for each clone. Once the insert was confirmed to be
present, clones that were positive for the insert were analyzed to determine that
the PCR product had been inserted in the correct orientation and was in frame
with the C-terminal histidine residues. To test for this, the pBAD Forward primer
(5’ ATGCCATAGCATTTTTATCC) was used with the specific insert’s reverse
primer. Use of the pBAD Forward primer adds 179 bp to the PCR product. Once
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the PCR had been verified by electrophoresis of the PCR product on an agarose
gel, one of the clones producing a band of the correct size was chosen and
stored frozen in glycerol at -80°C as the laboratory stock strain.

Expression of the Recombinant Proteins
Pilot expression experiments were performed on pBAD/smcol2 clones #2 and
#4, pBAD/gbscol1, and pBAD/gbscol2 to determine the optimal concentration of
arabinose for induction of the clones and the expression of the recombinant
proteins. pBAD/smcol2 clones # 2 and # 4 were chosen for further analysis since
they allowed for the production of the polyhistidine (6x) fusion protein tag, with
and without the signal peptide, respectively.

They were further termed

pBAD/smcol2sp, pBAD/smcol2wosp, respectively. pBAD/smcol2 clones #1 and
#3 were prepared in prevision of potential problem with enzyme activity being
influenced by the polyhistidine fusion protein tag (since this problem did not
occur, these two clones were not analyzed further). The expression experiment
was done according to the manufacturer’s protocol.

Briefly, the recombinant

clones were inoculated into 2 ml of LBA broth (100 µg/ml ampicillin) and grown
for 24 hours at 37ºC with constant shaking. The following day, 0.1 ml of the
overnight cultures was added to 10 ml of LBA and allowed to continue incubating
at 37ºC with constant shaking. The cultures were allowed to grow to an OD600 of
0.5, approximately 2.5 hours. A 1 ml sample of each culture was taken and the
cells were sedimented by centrifugation. The supernatant was aspirated and the
pellets were frozen for a zero time point sample. For each clone, cultures were
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induced at five different concentrations of L-arabinose: 0.2%, 0.02%, 0.002%,
0.0002%, and 0.00002%. Un-induced cultures were also grown that did not have
L-arabinose added to it. The cells were then allowed to grow for an additional 4
hours at 37ºC with constant shaking. Each culture was centrifuged to pellet the
cells. The supernatant was aspirated and the samples were frozen for further
analysis.

SDS-PAGE Analysis of Gene Expression in Recombinant E. coli
To determine if the recombinant bacteria produced the protein of interest, the
samples obtained above were analyzed by electrophoresis on a 10% SDSPolyacrylamide gel (1 mm). The cell pellets were thawed, resuspended in 20 µl
of 1x SDS-PAGE Sample Buffer (Bio-Rad) and boiled in a water bath for 5
minutes. The samples were then separated by electrophoresis using a MiniProtean II Electrophoresis Cell (Bio-Rad) at 200V for 1 hour. Once the samples
were separated through the gel, the gel was stained with 0.1% Coomassie blue
R-250 (in 40% methanol and 10% acetic acid) for one hour, then was destained
by incubation in a destaining solution (40% methanol and 10% acetic acid).
Numerous washes were used to totally destain the gel and obtain sharp protein
bands stained in blue.
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Western Blot Analysis of His-Tagged Fusion Protein
A Western immunoblot was performed by separating the samples by SDSPAGE and then transferring them to a nitrocellulose membrane. The proteins
were transferred to the nitrocellulose for one hour at 30V and 100 mA, with an ice
pack and constant stirring of the buffer using a Mini Trans-Blot® electrophoretic
transfer cell (Bio-Rad). The membrane was then blocked for 16 hours in 10 ml of
Western Blot Blocking Solution (5% dry milk in PBS containing 0.05% Tween 20
with) with gentle agitation. Next, the membrane was washed twice with 10 ml of
Western Blot Wash Buffer (PBS and 2% Tween 20) for 10 minutes each wash.
The primary antibody, murine anti-HisG (Invitrogen), was diluted 1:5000 in
Blocking Solution and incubated with the nitrocellulose for one hour at 24ºC with
gentle agitation.

The antibody was washed away with two washes of Wash

Buffer, 10 minutes each wash. Next, the membrane was incubated with the
secondary antibody, anti-mouse IgG antibody (Sigma) diluted 1:30,000 in
Blocking Buffer, for one hour at 24ºC with gentle agitation. The membrane was
washed again with Wash buffer, twice for 10 minutes each wash and then
developed. The nitrocellulose was developed via Dao’s method (8). Briefly, the
membrane is incubated with sodium borate buffer (60mM sodium tetraborate,
10mM magnesium sulfate, pH 9.7) containing 0.025% of O-dianisidine and
0.025% of β -naphthyl acid phosphate. After a 1 hour incubation in the buffer,
the membrane was fixed by incubating in Immunoblot Fixing Buffer (methanol:
H2O: acetic acid, 4:5:1). The membrane was then rinsed in deionized water and
allowed to dry.
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Purification of Recombinant Proteins
A fresh culture of the clones from the glycerol frozen stock was streaked onto
LBA plates and grown for 24 hours at 37ºC. A culture of competent cells that
contained the empty pBAD vector was used as a negative control.

The

recombinant clones were grown and induced as described above using the
optimal concentration of arabinose.

The fusion proteins were purified using

Qiagen’s Ni-NTA Fast Start Superflow Columns.

Purification was performed

under native conditions and as described by the manufacturer. The cell pellet
was resuspended in 10 ml of native lysis buffer, containing lysozyme and
benzonase and incubated on ice for 30 min. The lysate was centrifuged at
14,000 x g for 30 minutes at 4°C to pellet the cellular debris. The Fast Start
Columns were drained of the shipping buffer and the supernatant containing the
soluble fraction of the recombinant protein was applied to the column.

The

column was washed twice with 4 ml of Native Wash Buffer. The bound 6x Histagged protein was eluted out with two 1 ml aliquots of Native Elution Buffer. The
samples were analyzed by SDS-PAGE and Western Blot as described above.
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Protein Concentration
The protein concentration of all samples were determined by the BCA Protein
Assay developed by Bradford (4).

Briefly, a serial dilution of Bovine Serum

Albumin (BSA) was prepared and assayed along with the samples to be tested.
After addition of the BCA Working Reagent (Sigma) to the samples, they were
incubated for 15 minutes at 60°C and the absorption was read at OD595. The
values obtained from the BSA were used to develop a standard curve, which was
used to determine the protein concentration of the test samples.

Gelatinase assay
X-ray film coated with gelatin was stained with Coomassie blue R250, and
used to assay for gelatinase activity. Ten µl of each purified sample obtained
above was dotted onto the stained X-ray film, which was then placed in a humid
chamber (box with a piece of wet paper towel placed at the bottom). Incubation
was at 37oC for 16 hours, at which time the film was placed under running faucet
water. Dots containing digested gelatinase were identified by a cleared zone
exposing the shiny film backing.
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Collagenase Assay
Controls for the collagenase assay included C. histolyticum collagenase as a
positive control and trypsin as a negative control.

Purified SmCol2 with or

without the signal peptide, GBSCol1 with the signal peptide and GBSCol2 with
the signal peptide were prepared as follows: The samples were prepared by
growing 30 ml cultures for 24 hours at 37°C. The following day, the cells were
pelleted and the supernatant removed. The pellet was resuspended in 5 ml of
Gelatinase Assay Buffer (GAB: Tris-HCl with CaCl2 at pH 7.4) and freeze-thawed
3 times on dry ice and a 42°C water bath. The cells were then sonicated with
short bursts and centrifuged at 8,000 X g for 25 minutes. The supernatant was
poured off into clean tubes and the pellet was resuspended in 5 ml of assay
Buffer (50mM Tris buffer, 5 mM CaCl2 added at 5mM, pH 7.4). Purified fusion
proteins were isolated as described above and assayed for collagenase activity
using a specific blue collagenase substrate developed in our laboratory (Dao,
unpublished method).

Briefly, 100 µl of each sample (each sample was

approximately 600 µg/ml) were incubated separately with 1 ml suspension of
approximately 15 mg blue collagen type I from bovine tendon in assay buffer.
The enzymatic assay using blue collagen was referred to as “blue collagenase
assay” (proprietary method). After incubation in an incubator shaker at 37oC,
followed by centrifugation, degradation of collagen resulted in the blue coloration
of the supernatant, which was quantified by measuring the absorbance of the
blue dye at 500nm (OD500nm) using a spectrophotometer.
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RESULTS

Comparative Analysis between Putative Collagenase Genes of S. mutans
and GBS
The completed genomes of S. mutans UA159 (9), S. agalactiae strain
NEM316 serotype III (14) and S. agalactiae strain 2603V/R serotype V (43) have
been sequenced and, hence were used for this study. Analysis of the genomic
sequence of S. mutans UA159 revealed two proteases related to collagenase
(SMU.759 and SMU.761).

These genes were used to find similar genes in

Group B streptococci and compare their sequences with other known
collagenases from C. histolyticum and P. gingivalis. A BLink ("BLAST Link") was
performed using SMU.759 and SMU761 sequences. It was found that SAG0741
from S. agalactiae 2603V/R showed the highest similarities with SMU.759 (78%
homology, Figure 3) and SAG0742 from S. agalactiae 2603V/R showed the
highest similarities with SMU.761 (78% homology, Figure 2). These genes were
used for further analysis. SMU.761 was found to be 100% identical to smcol1,
cloned recently in our lab from GS-5 (NCBI Accession # AY644675) (21).
SMU.761 will be termed smcol1 and SMU.759 will be termed smcol2 for the
remainder of this study. The most closely related genes were selected for further
analysis (Table 2).
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Alignment Analysis
Comparative analysis of the deduced amino acid sequence of the genes of
interest was done using the alignment program, ClustalW WWW Service at the
European Bioinformatics Institute (6) (Table 2). SMU.761 (smcol1) showed high
homology to SAG0742 from S. agalactiae 2604V/R (78%) and gbs0763 from S.
agalactiae NEM316 (78%) (Figure 2). Minimal similarity was observed between
smcol1 and colG (2%) or colH (2%). SMU.759 (smcol2) was found to have
significant similarities with SAG0741 from S. agalactiae 2604V/R (77%) and
gbs0762 from S. agalactiae NEM316 (78%) (Figure 3), Minimal similarity was
found to colG and colH, 7% and 5% respectively.

Only 9% homology was

observed between smcol2 and smcol1.
Based on the sequence alignment, it was found that S. agalactiae 2603V/R
and S. agalactiae NEM316 presented parallel results with the sequences used
(Figure 2 and 3). Hence, SAG0742 and gbs0763 were determined to be the
same gene, as SAG0741 and gbs0762. They were termed gbscol1 and gbscol2,
respectively.
Gene
SMU.759
SMU.761
SAG0742
gbs0763
SAG0741
gbs0762
colH
colG
prtC

Organism
Streptococcus mutans UA159
Streptococcus mutans UA159
Streptococcus agalactiae 2603V/R
Streptococcus agalactiae NEM316
Streptococcus agalactiae 2603V/R
Streptococcus agalactiae NEM316
Clostridium histolyticum
Clostridium histolyticum
Porphyromonas gingivalis

Protein Function
Putative collagenase
Putative collagenase
Peptidase, U32
Hypothetical protein
Hypothetical protein
Hypothetical protein
Collagenase
Collagenase
Collagenase

Table 2. Genes selected for further bioinformatical analysis.
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Figure 3. Alignment of homology for smcol2
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Figure 4. Phylogram. Estimated phylogeny between the selected genes.
Branch lengths are proportional to the amount of inferred evolutionary change.

Tables of Homology
The sequence of smcol2, gbscol1 and gbscol2 was used as a query to
identify homologous genes in other bacteria and to deduce the corresponding
amino acid sequence and associated biochemical characteristics. The BLAST
analysis indicated high homology with the U32 family of peptidases and
collagenases of other related organisms (Tables 4, 5, and 6).
By using the S. mutans UA159 smcol2 sequence as a query, a BLAST
search showed 197 hits to 119 unique species (Table 3).

Analysis of the

deduced amino acid sequence showed notable homology with Streptococcus
suis collagenase (79%), Streptococcus pyogenes putative protease (77%) and S.
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pyogenes peptidase family U32 (76%).

It also showed homology to U32

peptidases of Enterococcus faecalis (53%) and Bacillus anthracis (31%).
Using the gbscol1 sequence as a query, a BLAST analysis was done to
determine which genes carried the most homology (Table 4). As expected, the
collagenases and U32 peptidases of Streptococcal species shared the highest
homology to gbscol1, ranging from 99%-82%. It was found that gbscol1 had
77% and 74% homology to Lactococcus lactis collagenase and Enterococcus
faecium U32 peptidase, respectively. It was also found that U32 peptidases from
Listeria monocytogenes and Staphylococcus epidermidis had 63% and 49%
homology, respectively.
Using the sequence of gbscol2 from S. agalactiae NEM316, a BLAST
search was performed to compare it to other organisms (Table 5). It was found
that it shared high homology with other Streptococcal collagenases and
peptidases of the U32 family: 79% homology with S. pyogenes, 76% homology
with S. suis, 72% homology with Streptococcus pneumoniae and 67%
Streptococcus thermophilus. It was also found that it shared 56% homology with
L. lactis and 55% homology with U32 peptidases from Enterococcus species.
Lastly, it was found that gbscol2 had 30% homology to U32 peptidases from
Bacillus species.
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Table 3. smcol2 homologous genes
30

Table 4. gbscol1 homologous genes
31

Table 5. gbscol2 homologous genes
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PCR Amplification and Cloning of the smcol2, gbscol1 and gbscol2 genes
into the pBAD-TOPO Vector
Using genomic DNA from S. mutans GS-5 as a template, PCR was used to
amplify smcol2. The primers were designed based on the sequenced genome of
S. mutans UA159 (9) and the PCR product obtained was cloned into the pBAD
TOPO® TA Cloning vector (Invitrogen).

The pBAD vector employs TOPO®

Cloning, an easy and efficient method of cloning PCR products. The linearized
vector has 3’ deoxyribose thymidine (dT) overhangs that are complementary to
the deoxyribose adenosine (dA) overhangs added by Taq polymerase to the 3’
end of PCR products. This allows for the direct incorporation of PCR amplicons
by Taq polymerase into the linearized plasmid vector. With TOPO® Cloning,
Topoisomerase I from Vaccinia virus is bound to the plasmid vector.

This

enzyme binds duplex DNA at specific sites and cleaves the phosphodiester
bonds on the vector backbone.

The energy generated from the broken

phosphodiester backbone creates a high energy covalent bond between a tyrosyl
residue of the enzyme and the phosphate residue of the cleaved DNA. This
leads to the release of Topoisomerase I through the attack of the phospho-tyrosyl
bond between the enzyme and the DNA by the 5′ hydroxyl of the original cleaved
strand. PCR products cloned into pBAD are regulated for expression in E. coli.
The expression of the PCR product in E. coli is determined by the araBAD
promoter (pBAD). The pBAD-TOPO® plasmid encodes for the AraC gene
product, which positively regulates this promoter. The expression of the pBAD
vector is controlled through the presence of L-arabinose. When L-arabinose is
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not present, transcription from pBAD is extremely low, while expression of pBAD
is turned on in the presence of L-arabinose. Protein expression levels can be
optimized by varying the concentration of L-arabinose.
Four primer sets were developed to amplify the gene with and without the
signal peptide. The gene was also amplified with and without the native stop. In
order to include the V5 epitope and the polyhistidine region of the pBAD vector,
the native stop must be removed. Once the PCR conditions were optimized for
the four primer sets and the PCR product had been verified on agarose gel
electrophoresis (Figure 5), it was cloned into the pBAD vector.
The cloning reaction mixture was used to transform E. coli TOP10 cells. After
an overnight incubation, each primer set produced numerous transformants.
Five ampicillin resistant (AmpR) transformants of each pBAD clone were chosen
at random for further screening. Plasmid DNA was isolated from the clones and
the presence of the insert was verified through PCR using the above primers.
Clones that produced plasmid that was positive for the corresponding PCR
product were subjected to further testing.

Clone 1
Clone 2
Clone 3
Clone 4

Forward Primer

Reverse Primer

Includes the signal peptide
Includes the signal peptide
Excludes the signal peptide
Excludes the signal peptide

Contains native stop
Does not contain native stop
Contains native stop
Does not contain native stop

MW of PCR
Product
927 bp
924 bp
702 bp
699 bp

Table 6. Primers designed for the cloning into the pBAD vector and the
anticipated molecular weight of the amplified product
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Once the insert had been confirmed to be present, the clones were analyzed
to determine that the PCR product had been inserted in the correct orientation
and were in frame with the C-terminal His tag. pBAD # 1 only produced one
clone that had the insert in the correct orientation, a band at 1106 bp (Figure 6A).
This lone clone was used for further investigation. Of the 5 clones screened,
pBAD # 2 had two clones in the correct orientation which produced bands at
1103 bp (Figure 6B). Figure 6C shows pBAD # 3 and pBAD # 4 also had two
clones, respectively, with the insert in the correct orientation and anticipated size;
881 bp and 878 bp for pBAD # 3 and pBAD # 4, respectively. Based on the PCR
results, it was concluded that the smcol2 had been successfully cloned into the
pBAD vector.

One clone that produced positive results for the PCR was

randomly chosen for further analysis.
The cloning of the gbscol1 and gbscol2 was as described for smcol2.
Primers were designed based on the sequenced genome of S. agalactiae
2603V/R and S. agalactiae NEM316 for the gbscol1 and gbscol2 gene. Once
PCR conditions had been optimized, the products were cloned in the pBAD
vector (Figure 7).
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Figure 5. PCR results using S. mutans GS-5 genomic DNA and custom
designed primers for smcol2
A. Lane 1: Molecular weight standard
Lane 2: PCR product for pBAD clone # 1 = 927 bp
B. Lane 1: Molecular weight standard
Lane 2: PCR product for pBAD clone # 2 = 924 bp
C. Lane 1: Molecular weight standard
Lane 2: PCR product for pBAD clone # 3 = 702 bp
Lane 3: PCR product for pBAD clone # 4 = 699 bp
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Figure 6. Confirmation of successful insertion and orientation of the smcol2 PCR
products into the pBAD vector using pBAD forward primer and the insert’s
reverse primer
A. Lane 1: Molecular weight standard
Lane 2: PCR conformation for pBAD clone # 1 = 1106 bp
B. Lane 1: Molecular weight standard
Lane 2: PCR confirmation for pBAD clone # 2a = 1103 bp
Lane 3: PCR confirmation for pBAD clone # 2b = 1103 bp
C. Lane 1: Molecular weight standard
Lane 2: PCR confirmation for pBAD clone # 3a = 881 bp
Lane 3: PCR confirmation for pBAD clone # 3b = 881 bp
Lane 4: PCR confirmation for pBAD clone # 4a = 878 bp
Lane 5: PCR confirmation for pBAD clone # 4b = 878 bp

37

Figure 7. PCR results using S. agalactiae USF704 genomic DNA and
custom- designed primers for gbscol1 and gbscol2
Lane 1: Molecular weight standard
Lane 2: PCR product for gbscol1 = 1284 bp
Lane 3: PCR product for gbscol2 = 924 bp

Figure 8: PCR confirmation of successful insertion in the pBAD vector
Figure 8A and 8C: Top lanes show plasmid isolated from pBAD/gbscol1 transformants.
The bottom lanes show PCR using the pBAD forward primer with the above
corresponding plasmid. Lanes 2 and 3 show bands at 1463 bp.
Figure 8B and 8D: Top lanes show plasmid isolated from pBAD/gbscol2 transformants.
The bottom lanes show PCR using the pBAD forward primer with the above
corresponding plasmid. Lanes 8 and 11 show bands at 1103 bp.
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Plasmid DNA was isolated from the clones (Figure 8, top) and the presence
of the insert was verified through PCR using the primers specific for the insert.
Clones that showed a band at 1284 bp for pBAD/gbscol1 and 924 bp for
pBAD/gbscol2 were analyzed to determine whether the insert had been inserted
in the correct orientation. Gbscol1 and Gbscol2 transformants both showed two
clones that had the insert positioned in the correct orientation (Figure 8, bottom).
These results show that the gbscol1 and gbscol2 had been successfully cloned
into the pBAD vector. One of each clone was chosen at random for further
studies.

Expression and Detection of pBAD/smcol2 through induction with
Arabinose, SDS-PAGE and Western Blot
Pilot expression experiments were performed on pBAD/smcol2 clone # 2,
pBAD/smcol2 clone # 4, pBAD/gbscol1 and pBAD/gbscol2 to determine the
optimal concentration of arabinose for induction of the clones and the expression
of the recombinant protein.

pBAD/smcol2 clone # 2 will be referred to as

smcol2sp (smcol2 with signal peptide) and pBAD/smcol2 clone # 4 will be
referred to as smcol2wosp (smcol2 without signal peptide) throughout the rest of
the paper. It was found that the highest production of the recombinant protein in
the clones was with 0.2% arabinose.

0.2% arabinose was then used for all

subsequent experiments as the inducer concentration.
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A Western blot was performed on clones smcol2sp, smcol2wosp, gbscol1
and gbscol2 using an anti-HisG antibody to definitely verify the size and the
production of the fusion protein in the corresponding induced recombinant
bacteria. As expected, smcol2sp clone produced a strong band at 40 kDa and
smcol2wosp clone produced a smaller band at 31 kDa (Figure 9). The negative
control (E. coli TOP10 transformed with pBAD-empty vector) showed no
reactivity to the anti-HisG antibody. The gbscol1 clone showed a strong band at
52.5 kDa whereas gbscol2 showed a band at about 40 kDa. This data confirms
that the four clones did produce successful induction of the polyhistidine (6xHis)
tagged fusion protein.

Figure 9: Western Blot of smcol2sp and smcol2wosp
Lane 1: Molecular weight standard
Lane 2: smcol2sp, 40 kDA
Lane 3: smcol2wosp; 31 kDA
Lane 4: Negative control, pBAD empty vector
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Purification of the polyhistidine (6xHis) tagged fusion proteins smcolsp,
smcolwosp, gbscol1 and gbscol2
A large-scale induction was performed on the four clones using 0.2%
arabinose. The presence of the recombinant protein in the induced cells was
verified through immunodot analysis using anti-HisG antibody (Figure 10) before
isolation. The recombinant protein was then isolated from the cells via Qiagen’s
NI-NTA Fast Start Columns (Catalog # 30600) using native conditions.

The

samples were separated by electrophoresis on an SDS-PAGE gel to confirm that
the protein of the correct size was isolated (Figure 11). The purified enzymes
were then verified to be the correct poly-histamine fusion recombinant protein
through Western Blot analysis using anti-HisG antibody.

Bands with the

anticipated molecular size were observed: 40 kDa smcol2sp, 31 kDa
smcol2wosp, 52.5 kDa gbscol1and 40 kDa gbscol2 on both the SDS-PAGE and
Western Blot (Figure 12). A Bradford assay was then performed to determine
the concentration of the isolated proteins.

It was found that the protein

concentration of each sample was as follows: smcol2sp, 559.8 ug/ml;
smcol2wosp, 580.9 ug/ml; gbscol1, 613.8 ug/ml; gbscol2, 538.9 ug/ml. These
samples were analyzed for collagenase activity.
pBAD Clones
smcol2sp
smcol2wosp
gbscol1
gbscol2

Size of protein (kDa )
40 kDa
31 kDa
52.5 kDa
40 kDa

pI
5.48
5.62
5.46
5.28

Table 7. pBAD clones and the anticipated protein size, including the pBAD
vector, and pI
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Figure 10: Immunodot of induced clones
Well 1: smcol2sp
Well 2: smcol2wosp
Well 3: gbscol1
Well 4: gbscol2

Figure 11: SDS-PAGE of purified recombinant enzymes
Lane 1: Molecular weight standard
Lane 2: Purified smcol2sp, 40 kDa
Lane 3: Purified smcol2wosp, 31 kDa
Lane 4: Purified gbscol1, 52.5 kDa
Lane 5: Purified gbscol2, 40 kDa
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Figure 12: Western Blot of purified enzymes
A. Lane 1: Molecular weight standard
Lane 2: Negative control
Lane 3: Purified smcol2sp, 40 kDa
B. Lane 1: Molecular weight standard
Lane 2: Negative control
Lane 3: Purified smcol2wosp, 31 kDa
C. Lane 1: Molecular weight standard
Lane 2: Negative control
Lane 3: Purified gbscol1, 52.5 kDa
D. Lane 1: Molecular weight standard
Lane 2: Negative control
Lane 3: Purified gbscol2, 40 kDa

Gelatinase Assay
All the samples tested, which included pure recombinant smcol2sp,
smcol2wosp, gbscol1 and gbscol2, were positive for gelatinase activity (Figure
13). As anticipated C. histolyticum collagenase, and trypsin, used as positive
controls, also degraded the gelatin. No gelatinase activity was observed with a
BSA dot.
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Figure 13. Gelatinase assay using X-Ray film
Top row: smcol2sp; smcol2wosp
Middle row: gbscol1; gbscol2
Bottom row: C. histolyticum collagenase; Trypsin
.

Blue Collagenase Assay
The Blue Collagenase Assay was used to determine whether or not the
recombinant proteins had true collagenase activity. As anticipated, C histolyticum
was strongly positive, whereas trypsin was negative (Figure 14). All recombinant
enzymes showed the presence of small collagen fragments adhering to the wall
of the tube (Figure 14). However, only smcol2sp and gbscol2 (also with the
signal peptide) showed some measurable degraded collagen (OD500nm)
(Table 8).

Samples
Abs OD500
Abs OD500
Mean
SD

gbscol1
0.0472
0.0728
0.060
0.018

gbscol2
0.1237
0.2268
0.175
0.072

smcol2sp
0.1965
0.1467
0.1716
0.035

smcol2wosp
0.034
0.0705
0.052
0.025

Table 8. Raw Data from Blue Collagenase Assay
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C. histolyticum
1.0985
0.913
1.006
0.130

Trypsin
0.075
0.015
0.045
0.042

1
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9

10

Figure 14. Blue collagenase assay
C. histolyticum collagenase (1) showing digestion of blue collagen
Trypsin (2) showing no degradation of collagen
Partial degradation of collagen into smaller fragments sticking to the tube wall
gbscol1 (3 & 4); gbscol2 (5 & 6); smcol2sp (7 & 8); smcol2wosp (9 & 10)

Blue Collagenase Assay
1.2

Absorbance (OD 500 nm)

1
0.8

0.6
0.4
0.2

0
1

2

3

4

5

6

Colla ge na se Sa m ple s

Figure 15: Results of Blue Collagenase Assay
Mean OD500nm of duplicate samples of:
1. Gbscol1
2. Gbscol2
3. Smcol2sp
4. Smcol2wosp
5. C. histolyticum collagenase
6. Trypsin
The absorbance observed with samples 1, 4 and 6 is equal to the background
level observed with blue collagen incubated in parallel with assay buffer alone.
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DISCUSSION
With the recent availability of completely sequenced microbial genomes,
analysis of S. mutans and GBS genomic sequences allowed the identification of
putative collagenase genes in these organisms. Of the putative collagenases
identified in S. mutans UA159, one identical gene (smcol1) was previously
cloned from S. mutans GS-5 and sequenced (21). Bioinformatical analysis of
the second putative collagenase gene, smcol2, indicated the possibility of it being
also a U32 collagenase. Homologous genes in GBS were identified in two S.
agalactiae strains NEM316 and 2603V/R. Subsequently, primers were designed
for the amplification of these genes using genomic DNA as a template. The PCR
products obtained were then cloned into an inducible vector system that allowed
for strict regulation of recombinant protein expression.
Recombinant clones harboring the genes of interest in the right orientation
were obtained and confirmed by PCR analysis, and the optimal recombinant
protein expression was achieved by induction with 0.2% arabinose. Expression
of the 6xHis-tagged fusion proteins was confirmed by western immunoblot
analysis. SDS-PAGE and Western blot analysis of smcol2sp and smcol2wosp
indicated that the presence of the signal peptide did not interfere with protein
expression. Hence, subsequent cloning of GBS collagenases was conducted
without removal of the signal peptide.
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As anticipated from His-tagged fusion protein, the purification of recombinant
proteins was much facilitated, and pure proteins were obtained and used in
determining their enzymatic activity. Previously, gelatinase activity was observed
with C. histolyticum collagenase (31), S. mutans (22) and GBS (23) but not with
P. gingivalis prtC collagenase (27). In the present study, gelatinase activity was
demonstrated for pure recombinant S. mutans and GBS recombinant enzymes,
thus indicating that these enzymes were not serine proteases like trypsin as they
were not inhibited by PMSF.

Since prtC collagenase was reported not to

degrade gelatin, the observation of gelatinase activity in S. mutans and GBS
enzymes denoted that members of the U32 family of peptidases/collagenases
were heterogeneous.
It was shown that these three enzymes, smcol2, gbscol1 and gbscol2, had
high degree of homology with other bacterial protease, most being U32
peptidases and collagenases (Tables 4, 5 and 6).

Based on the ProtoMap

database (46) all three enzymes were classified as members of the cluster, 1872.
This cluster contains 24 members, with 13 containing the Peptidase family U32
signature

It was also found that the European Molecular Biology Laboratory

(EMBL) database (1) grouped these proteins into family ENZYME: 3.4.-.- (E.C.
3.4), which are peptide hydrolases, acting on peptide bonds. This family contains
other well known collagenases from Vibrio alginolyticus and C. histolyticum.
Complete degradation of blue collagen by C. histolyticum collagenase and the
lack of digestion by trypsin demonstrated that the blue collagen substrate
prepared in our laboratory was useful in determining true collagenase activity.
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Generation of smaller fragments upon incubation with the recombinant proteins
indicated the presence of enzymes degrading partially the blue collagen
substrate, even when the incubation time was extended to 72 hours. Only the
smcol2sp and gbscol2 had the ability to degrade completely some of the
collagen. This apparent difference may be due to the fact that the C. histolyticum
collagenase sample contained a mixture of collagenases and proteases, or that
the 6x His-Tag might interfere with collagenase activity. Interestingly, smcol2sp
protein showed some complete collagenase activity, but not the smcol2wosp.
Considering that collagenase activity was observed with P. gingivalis bacteria,
but not with purified prtC enzyme, and that collagenase activity involved two
enzymes (20), it is hypothesized that perhaps the same holds true for the S.
mutans and GBS col1 and col2 enzymes.
Prior to the present study, a major obstacle was encountered due to the lack
of a true collagenase assay. Synthetic peptide substrate, acid soluble collagen
and denatured collagen used in commercially available collagenase assay kits
were found not to be specific for collagenase as none contained the typical triple
helix of native type I collagen (17). By using the specific blue collagenase assay
developed in our laboratory, we were able to observe complete and incomplete
collagen degradation activity by col1 and col2 in S. mutans and GBS. Since the
recombinant enzymes contained the signal peptide and the 6xHis-Tag, it is not
possible to extrapolate the data to the native enzymes, which may very well be
more active than the recombinant fusion proteins.

Nevertheless, the data

obtained in the present study already showed that the S. mutans and GBS
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collagenases, col1 and col2, had both collagenase and gelatinase activity, and
that they appeared to be distinct from both C. histolyticum collagenase and P.
gingivalis collagenase. Indeed, genetic analysis indicated that smcol1, smcol2,
gbscol1 and gbscol2 had essentially no homology to C. histolyticum
collagenases and moderate homology to P. gingivalis prtC enzymes. This is in
agreement with the distinct differences between bacterial Zn-metalloproteases
and U32 peptidases/collagenases, and the heterogeneity among members of the
U32 family.
In conclusion, the work presented herein has significantly added to our
understanding of S. mutans and GBS in dental root decay and premature rupture
of the amniochorionic membrane, and provided the direction for future studies.
Work is already underway in our laboratory by other members of our research
team to inactivate smcol1, smcol2, gbscol1 and gbscol2 by allelic exchange in S.
mutans and GBS to probe whether or not both enzymes are needed for
collagenase expression in the respective bacteria, to clone these genes into a
vector that will allow the purification of native enzymes for in vitro studies, and to
analyze collagenase expression as a function of growth state, planktonic versus
biofilms and to identify genes that are similarly regulated by microarray analysis.
.
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